Condition (MeSH)
Hearing Loss, Mixed Conductive-Sensorineural
ClinicalTrials.gov lists 43 trials for Hearing Loss, Mixed Conductive-Sensorineural or a narrower condition beneath it. Oticon Medical has the most among industry and government lead sponsors, with 16.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
43 of the 43 trials are tagged with Hearing Loss, Mixed Conductive-Sensorineural itself; the rest are tagged with a narrower condition beneath it.
When did Hearing Loss, Mixed Conductive-Sensorineural trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 5 |
| 2024 | 2 |
| 2023 | 3 |
| 2022 | 3 |
| 2021 | 5 |
| 2020 | 2 |
| 2019 | 4 |
| 2018 | 1 |
| 2017 | 5 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 32 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 13 months across 33 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hearing Loss, Mixed Conductive-Sensorineural trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2/3 | 1 |
| Phase 4 | 1 |
| Not applicable | 32 |
| Observational | 9 |
How many Hearing Loss, Mixed Conductive-Sensorineural trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Completed | 30 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hearing Loss, Mixed Conductive-Sensorineural trials? (8)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Oticon Medical | 16 |
| Cochlear | 11 |
| MED-EL Elektromedizinische Geräte GesmbH | 3 |
| Med-El Corporation | 3 |
| Cochlear Bone Anchored Solutions | 2 |
Showing 5 of 8 sponsors.
Which serious adverse events do Hearing Loss, Mixed Conductive-Sensorineural trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Implant site pain | 2 | 1 |
| Pneumonia | 2 | 2 |
| Accidental Death | 1 | 1 |
| Aortic valve replacement | 1 | 1 |
| Atrial fibrilation | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Hearing Loss, Mixed Conductive-Sensorineural? (16)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Clinical performance, safety, and patient-reported outcomes of an active osseointegrated bone-conduction hearing implant system at 24-month follow-up. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2024 | Yes |
| Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2023 | Yes |
| Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2022 | Yes |
| Clinical Performance, Safety, and Patient-Reported Outcomes of an Active Osseointegrated Steady-State Implant System. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology | 2022 | Yes |
| Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology | 2021 | Yes |
Showing 5 of 16 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: drugs tested, prevalence, rare-disease identity, and sub-conditions in mesh.